| Missing Links?: 1093 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 10146,
Authors: 16970,
Journals: 1137,
Outer References: 208320,
Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name.
Page 22 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 2101 | 4 | 80 | 2129 1970 CANCER CHEMOTHERAPY REPORTS PART 1 54 (6): 431-& SKIPPER HE; SCHABEL FM; MELLETT B; MONTGOMERY JA; WILKOFF LJ; et al. IMPLICATIONS OF BIOCHEMICAL, CYTOKINETIC, PHARMACOLOGIC, AND TOXICOLOGIC RELATIONSHIPS IN DESIGN OF OPTIMAL THERAPEUTIC SCHEDULES | 3 | 312 |
| 2102 | 2 | 17 | 2470 1971 CANCER CHEMOTHERAPY REPORTS PART 1 55 (3): 285-& SUTOW WW; WILBUR JR; VIETTI TJ; VUTHIBHA.P; FUJIMOTO T; et al. EVALUATION OF DOSAGE SCHEDULES OF MITOMYCIN-C (NSC-26980) IN CHILDREN/N | 2 | 13 |
| 2103 | 5 | 40 | 3550 1974 CANCER CHEMOTHERAPY REPORTS PART 1 58 (4): 527-538 BYFIELD JE ROLE OF RADIATION REPAIR MECHANISMS IN RADIATION TREATMENT FAILURES | 2 | 16 |
| 2104 | 92 | 294 | 3551 1974 CANCER CHEMOTHERAPY REPORTS PART 1 58 (4): 539-557 SZYBALSKI W X-RAY SENSITIZATION BY HALOPYRIMIDINES | 193 | 193 |
| 2105 | 20 | 211 | 1574 1968 CANCER CHEMOTHERAPY REPORTS PART 2 1 (1): 1-& GOLDIN A; WOOD HB; ENGLE RR RELATION OF STRUCTURE OF PURINE AND PYRIMIDINE NUCLEOSIDES TO ANTITUMOR ACTIVITY | 2 | 60 |
| 2106 | 5 | 104 | 3552 1974 CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT 4 (1): 115-129 BROCKMAN RW BIOCHEMICAL ASPECTS OF DRUG COMBINATIONS | 4 | 30 |
| 2107 | 4 | 17 | 1575 1968 CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT 1 (1): 81-& CARTER SK PORFIROMYCIN (NSC-56410)--CLINICAL BROCHURE | 2 | 6 |
| 2108 | 7 | 17 | 3553 1974 CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT 4 (4): 23-25 LIN AJ; COSBY LA; SARTORELLI AC QUINONES AS ANTICANCER AGENTS - POTENTIAL BIOREDUCTIVE ALKYLATING-AGENTS | 16 | 0 |
| 2109 | 5 | 54 | 3908 1975 CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT 6 (2): 91-106 DIMARCO A ADRIAMYCIN (NSC-123127) - MODE AND MECHANISM OF ACTION | 11 | 300 |
| 2110 | 14 | 35 | 8480 1991 CANCER COMMUNICATIONS 3 (2): 29-35 HUGHES CS; IRVIN CG; ROCKWELL S EFFECT OF DEFICIENCIES IN DNA-REPAIR ON THE TOXICITY OF MITOMYCIN-C AND PORFIROMYCIN TO CHO CELLS UNDER AEROBIC AND HYPOXIC CONDITIONS | 13 | 26 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2111 | 17 | 43 | 8481 1991 CANCER COMMUNICATIONS 3 (6): 191-198 ROCKWELL S; KEYES SR; LOOMIS R; KELLEY M; VYAS DM; et al. ACTIVITY OF C-7 SUBSTITUTED CYCLIC ACETAL DERIVATIVES OF MITOMYCIN-C AND PORFIROMYCIN AGAINST HYPOXIC AND OXYGENATED EMT6 CARCINOMA-CELLS INVITRO AND INVIVO | 3 | 10 |
| 2112 | 27 | 50 | 8482 1991 CANCER COMMUNICATIONS 3 (7): 213-223 TOMASZ M; HUGHES CS; CHOWDARY D; KEYES SR; LIPMAN R; et al. ISOLATION, IDENTIFICATION, AND ASSAY OF [H-3] PORFIROMYCIN ADDUCTS OF EMT6 MOUSE MAMMARY-TUMOR CELL-DNA - EFFECTS OF HYPOXIA AND DICUMAROL ON ADDUCT PATTERNS | 14 | 26 |
| 2113 | 28 | 49 | 8483 1991 CANCER COMMUNICATIONS 3 (10-11): 351-356 KEYES SR; LOOMIS R; DIGIOVANNA MP; PRITSOS CA; ROCKWELL S; et al. CYTOTOXICITY AND DNA CROSS-LINKS PRODUCED BY MITOMYCIN ANALOGS IN AEROBIC AND HYPOXIC EMT6 CELLS | 15 | 33 |
| 2114 | 12 | 37 | 9774 2000 CANCER GENE THERAPY 7 (5): 778-788 Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; et al. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion | 0 | 11 |
| 2115 | 5 | 36 | 5944 1981 CANCER GENETICS AND CYTOGENETICS 3 (2): 161-169 SAYER AM; LITTLEFIELD LG; DUFRAIN RJ; RICHTER CB ANALYSIS OF MUTAGEN-INDUCED CHROMOSOME-DAMAGE IN A PRIMATE SPECIES (SAGUINUS-OEDIPUS OEDIPUS) AT RISK FOR SPONTANEOUS ADENOCARCINOMA OF THE COLON | 0 | 6 |
| 2116 | 3 | 20 | 6597 1983 CANCER GENETICS AND CYTOGENETICS 8 (4): 297-305 KELLOW GN; GRAVES JAM EVIDENCE FOR AN INDIRECT EFFECT OF RADIATION ON MAMMALIAN CHROMOSOMES .2. UV-INDUCED ISOCHROMOSOME FORMATION IN CELL HYBRIDS | 2 | 4 |
| 2117 | 19 | 240 | 8659 1992 CANCER INVESTIGATION 10 (6): 533-551 SHENOY MA; SINGH BB CHEMICAL RADIOSENSITIZERS IN CANCER-THERAPY | 0 | 12 |
| 2118 | 16 | 165 | 9335 1996 CANCER INVESTIGATION 14 (1): 66-82 Maher LJ Prospects for the therapeutic use of antigene oligonucleotides | 0 | 67 |
| 2119 | 4 | 18 | 3909 1975 CANCER LETTERS 1 (2): 91-96 YAHAGI T; DEGAWA M; SEINO Y; MATSUSHIMA T; NAGAO M; et al. MUTAGENICITY OF CARCINOGENIC AZO DYES AND THEIR DERIVATIVES | 7 | 295 |
| 2120 | 3 | 15 | 4625 1977 CANCER LETTERS 2 (6): 355-360 MARTIN CN; MCDERMID AC; GARNER RC MEASUREMENT OF UNSCHEDULED DNA-SYNTHESIS IN HELA-CELLS BY LIQUID SCINTILLATION-COUNTING AFTER CARCINOGEN TREATMENT | 1 | 19 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2121 | 5 | 14 | 5271 1979 CANCER LETTERS 7 (2-3): 141-146 KRIEK E EFFECT OF PH ON THE RATIO OF SUBSTITUTION PRODUCTS IN DNA AFTER REACTION WITH THE CARCINOGEN N-ACETOXY-2-ACETYLAMINOFLUORENE | 1 | 15 |
| 2122 | 2 | 29 | 5945 1981 CANCER LETTERS 12 (4): 311-321 BERKOWITZ EML; SILK H METHYLATION OF CHROMOSOMAL DNA BY 2 ALKYLATING-AGENTS DIFFERING IN CARCINOGENIC POTENTIAL | 0 | 19 |
| 2123 | 0 | 9 | 7455 1986 CANCER LETTERS 31 (3): 305-309 MOOLTEN FL INVIVO EFFICACY OF HAT THERAPY AGAINST TRANSPLANTABLE MURINE MYELOMAS RESISTANT TO PURINE ANALOGS | 0 | 2 |
| 2124 | 11 | 19 | 8088 1989 CANCER LETTERS 45 (3): 173-176 BEGLEITER A; ROBOTHAM E; LACEY G; LEITH MK INCREASED SENSITIVITY OF QUINONE RESISTANT CELLS TO MITOMYCIN-C | 19 | 57 |
| 2125 | 1 | 27 | 8290 1990 CANCER LETTERS 55 (2): 115-120 CAVALIERE A; PIETROPAOLI N; ALBERTI PF; VITALI R CHLORAMBUCIL CARCINOGENESIS IN BALB/C MICE | 0 | 0 |
| 2126 | 3 | 24 | 8844 1993 CANCER LETTERS 70 (1-2): 81-90 ANISIMOV VN; OSIPOVA GY CARCINOGENESIS INDUCED BY COMBINED NEONATAL EXPOSURE TO 5-BROMO-2'- DEOXYURIDINE AND SUBSEQUENT TOTAL-BODY X-RAY-IRRADIATION IN RATS | 0 | 4 |
| 2127 | 23 | 31 | 9170 1995 CANCER LETTERS 90 (2): 133-138 PETERSON DM; FISHER J; BEALL HD; ROSS D NONCOVALENT BINDING OF A MITOMYCIN-C METABOLITE, 2,7-DIAMINOMITOSENE, TO DUPLEX DNA | 2 | 5 |
| 2128 | 1 | 5 | 106 1955 CANCER RESEARCH 15 (3): 143-146 SKIPPER HE; SCHABEL FM; BINNS V; THOMSON JR; WHEELER GP STUDIES ON THE MECHANISM OF ACTION AND ANTICANCER ACTIVITY OF N-METHYLFORMAMIDE | 1 | 26 |
| 2129 | 2 | 96 | 136 1956 CANCER RESEARCH 16: 698-716 LAW LW DIFFERENCES BETWEEN CANCERS IN TERMS OF EVOLUTION OF DRUG RESISTANCE | 10 | 73 |
| 2130 | 4 | 245 | 164 1957 CANCER RESEARCH 17 (8): 727-757 SWANN MM THE CONTROL OF CELL DIVISION - A REVIEW .1. GENERAL MECHANISMS | 7 | 213 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2131 | 1 | 23 | 202 1958 CANCER RESEARCH 18 (2): 214-219 HUTCHISON DJ METABOLISM OF RESISTANT MUTANTS OF STREPTOCOCCUS-FAECALIS .1. ISOLATION AND CHARACTERIZATION OF THE MUTANTS | 9 | 50 |
| 2132 | 1 | 253 | 297 1960 CANCER RESEARCH 20 (8): 1121-1148 KIT S NUCLEIC ACID SYNTHESIS IN THE NEOPLASTIC CELL AND IMPACT OF NUCLEAR CHANGES ON THE BIOCHEMISTRY OF TUMOR TISSUE - A REVIEW | 8 | 36 |
| 2133 | 1 | 35 | 366 1961 CANCER RESEARCH 21 (1): 118-& HENDERSON J; JUNGA IG METABOLISM OF 4-AMINOPYRAZOLO (3,4-D)PYRIMIDINE IN NORMAL AND NEOPLASTIC TISSUES | 0 | 33 |
| 2134 | 2 | 40 | 367 1961 CANCER RESEARCH 21 (3): 345-& HAMPTON EG; EIDINOFF ML ADMINISTRATION OF 5-IODODEOXYURIDINE-I131 IN MOUSE AND RAT | 28 | 51 |
| 2135 | 2 | 22 | 368 1961 CANCER RESEARCH 21 (4): 550-& CALABRESI P; FINCH SC; CHU MY; CARDOSO SS; WELCH AD; et al. INITIAL CLINICAL STUDIES WITH 5-IODO-2'-DEOXYURIDINE | 43 | 122 |
| 2136 | 2 | 145 | 369 1961 CANCER RESEARCH 21 (8): 957-& HAUSCHKA TS CHROMOSOMES IN ONTOGENY AND ONCOGENY | 5 | 211 |
| 2137 | 4 | 102 | 370 1961 CANCER RESEARCH 21 (9): 1086-& HOLLAND JF CHEMOTHERAPY AND CHEMOPRAXIS OF CANCER, 1961 | 3 | 15 |
| 2138 | 5 | 34 | 371 1961 CANCER RESEARCH 21 (9): 1141-& KRISS JP; REVESZ L QUANTITATIVE STUDIES OF INCORPORATION OF EXOGENOUS THYMIDINE AND 5-BROMODEOXYURIDINE INTO DEOXYRIBONUCLEIC ACID OF MAMMALIAN CELLS IN VITRO | 20 | 42 |
| 2139 | 1 | 109 | 372 1961 CANCER RESEARCH 21 (10): 1334-& GOLDIN A; VENDITTI JM; MANTEL N PRECLINICAL SCREENING AND EVALUATION OF AGENTS FOR CHEMOTHERAPY OF CANCER - A REVIEW | 2 | 37 |
| 2140 | 1 | 18 | 474 1962 CANCER RESEARCH 22 (1): 3-& RICH MA; PEREZ AG; EIDINOFF ML EFFECTS OF SOME PURINE ANALOGS ON GROWTH OF H.EP. NUMBER 1 AND CHICK EMBRYO FIBROBLAST CELLS | 2 | 6 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2141 | 3 | 28 | 475 1962 CANCER RESEARCH 22 (2): 254-& KRISS JP; REVESZ L DISTRIBUTION AND FATE OF BROMODEOXYURIDINE AND BROMODEOXYCYTIDINE IN MOUSE AND RAT | 66 | 163 |
| 2142 | 6 | 534 | 476 1962 CANCER RESEARCH 22 (6): 651-& WHEELER GP STUDIES RELATED TO MECHANISMS OF ACTION OF CYTOTOXIC ALKYLATING AGENTS - A REVIEW | 28 | 318 |
| 2143 | 2 | 80 | 477 1962 CANCER RESEARCH 22 (7): 779-& BIESELE JJ EXPERIMENTAL AND THERAPEUTIC MODIFICATION OF MITOSIS | 4 | 15 |
| 2144 | 2 | 43 | 478 1962 CANCER RESEARCH 22 (8): 906-& MURPHY WH; BULLIS C; ACOSTA R; LANDAU BJ EFFECTS OF HETEROLOGOUS SERA ON MODAL DISTRIBUTION OF VARIANTS IN 4 STRAINS OF HUMAN EPITHELIAL CELLS | 0 | 10 |
| 2145 | 4 | 25 | 479 1962 CANCER RESEARCH 22 (8): 987-& HAKALA MT; ISHIHARA T CHROMOSOMAL CONSTITUTION AND AMETHOPTERIN RESISTANCE IN CULTURED MOUSE CELLS | 2 | 45 |
| 2146 | 5 | 21 | 480 1962 CANCER RESEARCH 22 (10): 1257-& KRISS JP; BOND S; TUNG L DISTRIBUTION AND FATE OF IODODEOXYCYTIDINE IN MOUSE AND RAT | 23 | 44 |
| 2147 | 3 | 45 | 481 1962 CANCER RESEARCH 22 (11): 1290-& PAIGEN K PREDICTION OF GROWTH-INHIBITORY DRUG COMBINATIONS SHOWING ENHANCED DIFFERENTIAL TOXICITY AND COLLATERAL SENSITIVITY | 2 | 3 |
| 2148 | 14 | 30 | 620 1963 CANCER RESEARCH 23 (1): 122-& ERIKSON RL; SZYBALSKI W MOLECULAR RADIOBIOLOGY OF HUMAN CELL LINES .3. RADIATION-SENSITIZING PROPERTIES OF 5-IODODEOXYURIDINE | 71 | 71 |
| 2149 | 8 | 26 | 621 1963 CANCER RESEARCH 23 (2): 260-& KRISS JP; BOND SB; TUNG LA; MARUYAMA Y; REVESZ L FATE OF 5-BROMODEOXYURIDINE, 5-BROMODEOXYCYTIDINE, AND 5-IODODEOXYCYTIDINE IN MAN | 42 | 98 |
| 2150 | 10 | 37 | 622 1963 CANCER RESEARCH 23 (4): 583-& CALABRESI P; WELCH AD; PRUSOFF WH; CREASEY WA CLINICAL AND PHARMACOLOGICAL STUDIES WITH 5-IODO-2-DEOXYCYTIDINE | 18 | 32 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2151 | 1 | 66 | 623 1963 CANCER RESEARCH 23 (7): 961-& GELLHORN A UNIFYING THREAD | 0 | 26 |
| 2152 | 7 | 93 | 624 1963 CANCER RESEARCH 23 (8): 1191-& BROCKMAN RW BIOCHEMICAL ASPECTS OF MERCAPTOPURINE INHIBITION AND RESISTANCE | 9 | 82 |
| 2153 | 17 | 136 | 625 1963 CANCER RESEARCH 23 (8): 1246-& PRUSOFF WH A REVIEW OF SOME ASPECTS OF 5-IODODEOXYURIDINE AND AZAURIDINE | 28 | 85 |
| 2154 | 6 | 47 | 626 1963 CANCER RESEARCH 23 (8): 1260-& CALABRESI P CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2-DEOXYURIDINE, AND RELATED DERIVATIVES | 8 | 55 |
| 2155 | 1 | 88 | 627 1963 CANCER RESEARCH 23 (8): 1428-& REICH E BIOCHEMISTRY OF ACTINOMYCINS | 20 | 227 |
| 2156 | 13 | 31 | 628 1963 CANCER RESEARCH 23 (11): 1715-& CLIFTON KH; HEIDELBERGER C; GOLLIN FF; ANSFIELD FJ; SZYBALSKI W; et al. INCORPORATION OF I125-LABELED IODODEOXYURIDINE INTO DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES | 41 | 41 |
| 2157 | 2 | 50 | 779 1964 CANCER RESEARCH 24 (4P1): 603-& SMITH AG CYTOLOGIC + CYTOTOXIC CHANGES INDUCED BY NUCLEIC ACIDS | 9 | 16 |
| 2158 | 2 | 17 | 780 1964 CANCER RESEARCH 24 (11P): 1979-& HEIDELBERGER C; ANDERSON SW FLUORINATED PYRIMIDINES .21. TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2]-DEOXYURIDINE | 12 | 51 |
| 2159 | 9 | 52 | 976 1965 CANCER RESEARCH 25 (2P1): 234-& FOX BW; PRUSOFF WH COMPARATIVE UPTAKE OF I125-LABELED 5-IODO-2'-DEOXYURIDINE AND THYMIDINE-H3 INTO TISSUES OF MICE BEARING HEPATOMA-129 | 10 | 69 |
| 2160 | 3 | 21 | 977 1965 CANCER RESEARCH 25 (3P1): 377-& HEIDELBERGER C; BOOHAR J; KAMPSCHR.B FLUORINATED PYRIMIDINES .24. IN VIVO METABOLISM OF K-TRIFLUOROMETHYLURACIL-4-C14 AND 5-TRIFLUOROMETHYL-2'2DEOXYURIDINE-2-C14 | 6 | 35 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2161 | 1 | 365 | 978 1965 CANCER RESEARCH 25 (4SP2): 645-& [Anon] ABSTRACTS | 0 | 0 |
| 2162 | 2 | 107 | 979 1965 CANCER RESEARCH 25 (4SP2): 924-& [Anon] ABSTRACTS | 0 | 0 |
| 2163 | 1 | 113 | 980 1965 CANCER RESEARCH 25 (4SP2): 945-& [Anon] ABSTRACTS | 0 | 0 |
| 2164 | 2 | 70 | 981 1965 CANCER RESEARCH 25 (5P1): 628-& LAPIS K; BERNHARD W EFFECT OF MITOMYCIN-C ON NUCLEOLAR FINE STRUCTURE OF KB CELLS IN CELL CULTURE | 14 | 74 |
| 2165 | 3 | 24 | 982 1965 CANCER RESEARCH 25 (5P1): 760-& LOWRY GM ADDITIVE CYTOTOXICITY OF 5-FLUOROURACIL AND GAMMA-RADIATION ON DIPLOID CELL STRAINS | 1 | 4 |
| 2166 | 1 | 35 | 983 1965 CANCER RESEARCH 25 (6P1): 902-& SIVAK A; ROGERS WI; WODINSKY I; KENSLER CJ STUDIES ON FORMATION OF PHTHALANILIDE-DEOXYRIBONUCLEIC ACID COMPLEXES AND THEIR RELATIONSHIP TO CHEMOTHERAPEUTIC ACTIVITY | 0 | 16 |
| 2167 | 7 | 45 | 984 1965 CANCER RESEARCH 25 (9P1): 1393-& SARTORELLI AC; BOOTH BA SYNERGISTIC ANTI-NEOPLASTIC ACTIVITY OF COMBINATIONS OF MITOMYCINS WITH EITHER 6-THIOGUANINE OR 5-FLUOROURACIL | 10 | 44 |
| 2168 | 11 | 78 | 985 1965 CANCER RESEARCH 25 (9P1): 1581-& HUTCHISO.DJ STUDIES ON CROSS-RESISTANCE AND COLLATERAL SENSITIVITY (1962-1964) | 0 | 27 |
| 2169 | 7 | 61 | 986 1965 CANCER RESEARCH 25 (9P1): 1596-& BROCKMAN RW RESISTANCE TO PURINE ANTAGONISTS IN EXPERIMENTAL LEUKEMIA SYSTEMS | 6 | 50 |
| 2170 | 2 | 56 | 987 1965 CANCER RESEARCH 25 (9P1): 1643-& BERGEL F; HARRAP KR FUTURE POSSIBILITIES FOR DEVELOPMENT OF TREATMENTS OF LEUKEMIA | 0 | 3 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2171 | 2 | 28 | 988 1965 CANCER RESEARCH 25 (10): 1764-& RAO RN; NATARAJA.AT EFFECT OF 9-BETA-D-ARABINOFURANOSYLADENINE ON VICIA FABA CHROMOSOMES | 0 | 4 |
| 2172 | 4 | 60 | 1177 1966 CANCER RESEARCH 26 (7P1): 1313-& HOFFMAN J; POST J REPLICATION AND 5-IODO-2'-DEOXYURIDINE-3H INCORPORATION BY TUMOR AND NORMAL CELLS | 3 | 17 |
| 2173 | 2 | 22 | 1178 1966 CANCER RESEARCH 26 (8P1): 1801-& REID BD; WALKER IG RESISTANCE TO SULFUR MUSTARD - A COMPARISON OF SOME PROPERTIES OF STRAIN L CELLS AND A RESISTANT SUBLINE | 1 | 11 |
| 2174 | 3 | 38 | 1179 1966 CANCER RESEARCH 26 (9P1): 1859-& KIT S; DETORRES RA; DUBBS DR ARABINOFURANOSYLCYTOSINE-INDUCED STIMULATION OF THYMIDINE KINASE AND DEOXYCYTIDYLIC DEAMINASE ACTIVITIES OF MAMMALIAN CULTURES | 4 | 53 |
| 2175 | 5 | 49 | 1180 1966 CANCER RESEARCH 26 (9P1): 2045-& HUTCHINS.F MOLECULAR BASIS FOR RADIATION EFFECTS ON CELLS | 0 | 30 |
| 2176 | 2 | 39 | 1181 1966 CANCER RESEARCH 26 (11P1): 2229-& LAZARUS SS; VETHAMAN.VG; SHAPIRO SH; AMSTERDA.D HISTOCHEMISTRY AND FINE STRUCTURE OF 4-NITROQUINOLINE-N-OXIDE-INDUCED NUCLEAR INCLUSIONS | 0 | 19 |
| 2177 | 2 | 28 | 1182 1966 CANCER RESEARCH 26 (12P1): 2419-& GRAY GD; CAMIENER GW; BHUYAN BK NOGALAMYCIN EFFECTS IN RAT LIVER - INHIBITION OF TRYPTOPHAN PYRROLASE INDUCTION AND NUCLEIC ACID BIOSYNTHESIS | 7 | 16 |
| 2178 | 5 | 27 | 1379 1967 CANCER RESEARCH 27 (1): 175-& GLICK JL SPECIFICITY OF INHIBITION OF L1210 TUMOR GROWTH BY MOUSE THYMUS DEOXYRIBONUCLEIC ACID | 8 | 17 |
| 2179 | 2 | 32 | 1380 1967 CANCER RESEARCH 27 (2P1): 367-& SIRTORI C; BOSISIOB.M NUCLEOLAR CHANGES IN KB TUMOR CELLS INFECTED WITH HERPES SIMPLEX VIRUS | 0 | 32 |
| 2180 | 3 | 17 | 1381 1967 CANCER RESEARCH 27 (4): 632-& MILLER DS; LASZLO J; MCCARTY KS; GUILD WR; HOCHSTEI.P MECHANISM OF ACTION OF STREPTONIGRIN IN LEUKEMIC CELLS | 6 | 39 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2181 | 1 | 48 | 1382 1967 CANCER RESEARCH 27 (7): 1248-& CHMIELEW.ZF; FIEL RJ; BARDOS TJ; AMBRUS JL ALTERATIONS OF SOME MACROMOLECULAR AND BIOCHEMICAL PROPERTIES OF CALF THYMUS DNA CAUSED BY DUAL ANTAGONISTS AND NITROGEN MUSTARD | 0 | 11 |
| 2182 | 3 | 62 | 1383 1967 CANCER RESEARCH 27 (9): 1658-& RACELA A; GRADY H; SVOBODA D ULTRASTRUCTURAL NUCLEAR CHANGES DUE TO TANNIC ACID | 0 | 27 |
| 2183 | 9 | 18 | 1384 1967 CANCER RESEARCH 27 (12P1): 2338-& GLICK JL SPECIFICITY OF INHIBITION OF TUMOR CELL VIABILITY BY DNA | 6 | 13 |
| 2184 | 7 | 26 | 1385 1967 CANCER RESEARCH 27 (12P1): 2342-& GLICK JL; SAHLER C SPECIFIC METABOLIC CHANGES IN DNA-TREATED L1210 LEUKEMIA CELLS | 6 | 11 |
| 2185 | 11 | 45 | 1386 1967 CANCER RESEARCH 27 (12P1): 2350-& GLICK JL QUANTITATIVE STUDIES CONCERNING UPTAKE OF MOUSE THYMUS DNA BY L1210 LEUKEMIA CELLS | 5 | 11 |
| 2186 | 1 | 47 | 1576 1968 CANCER RESEARCH 28 (3): 535-& BELMAN S; TROLL W; TEEBOR G; MUKAI F CARCINOGENIC AND MUTAGENIC PROPERTIES OF N-HYDROXY-AMINONAPHTHALENES | 11 | 86 |
| 2187 | 4 | 21 | 1577 1968 CANCER RESEARCH 28 (4): 758-& BHUYAN BK; BETZ T STUDIES ON MODE OF ACTION OF COPPER(2)CHELATE OF 2-KETO-3-ETHOXYBUTYRALDEHYDE-BIS(THIOSEMICARBAZONE) | 0 | 10 |
| 2188 | 4 | 23 | 1578 1968 CANCER RESEARCH 28 (5): 938-& KESSEL D; BOTTERIL.V; WODINSKY I UPTAKE AND RETENTION OF DAUNOMYCIN BY MOUSE LEUKEMIC CELLS AS FACTORS IN DRUG RESPONSE | 6 | 154 |
| 2189 | 6 | 32 | 1579 1968 CANCER RESEARCH 28 (6): 1150-& MAURO F; ELKIND MM DIFFERENCES IN SURVIVAL VARIATIONS DURING GROWTH CYCLE OF CULTURED CHINESE HAMSTER CELLS TREATED WITH SULFUR MUSTARD AND X-RAYS | 2 | 28 |
| 2190 | 2 | 42 | 1580 1968 CANCER RESEARCH 28 (11): 2349-& VANDUURE.BL; SIVAK A TUMOR-PROMOTING AGENTS FROM CROTON TIGLIUM L AND THEIR MODE OF ACTION | 0 | 34 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2191 | 3 | 24 | 1581 1968 CANCER RESEARCH 28 (12): 2437-& KIM JH; GELBARD AS; DJORDJEVIC B; KIM SH; PEREZ AG ACTION OF DAUNOMYCIN ON NUCLEIC ACID METABOLISM AND VIABILITY OF HELA CELLS | 10 | 45 |
| 2192 | 5 | 21 | 1582 1968 CANCER RESEARCH 28 (12): 2443-& KIM JH; PEREZ AG; DJORDJEVIC B STUDIES ON UNBALANCED GROWTH IN SYNCHRONIZED HELA CELLS | 2 | 49 |
| 2193 | 3 | 36 | 1848 1969 CANCER RESEARCH 29 (3): 497-& SIDWELL RW; DIXON GJ; COMPTON P; SCHABEL FM EFFECT OF TREATMENT WITH A COMBINATION OF 6-MERCAPTOPURINE AND PORFIROMYCIN ON AN ESTABLISHED FRIEND LEUKEMIA VIRUS INFECTION | 0 | 1 |
| 2194 | 2 | 23 | 1849 1969 CANCER RESEARCH 29 (3): 687-& KARON M; SHIRAKAW.S LOCUS OF ACTION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CELL CYCLE | 2 | 118 |
| 2195 | 1 | 31 | 1850 1969 CANCER RESEARCH 29 (5): 1036-& BACH MK BIOCHEMICAL AND GENETIC STUDIES OF A MUTANT STRAIN OF MOUSE LEUKEMIA L1210 RESISTANT TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE (CYTARABINE) HYDROCHLORIDE | 0 | 36 |
| 2196 | 2 | 8 | 1851 1969 CANCER RESEARCH 29 (7): 1367-& JOHNSON HG; BACH MK APPARENT ANTIMUTAGENIC ACTIVITY OF QUINACRINE HYDROCHLORIDE IN DETROIT-98 HUMAN STERNAL MARROW CELLS GROWN IN CULTURE | 0 | 10 |
| 2197 | 4 | 16 | 1852 1969 CANCER RESEARCH 29 (8): 1507-& RUSCONI A; DIMARCO A INHIBITION OF NUCLEIC ACID SYNTHESIS BY DAUNOMYCIN AND ITS RELATIONSHIP TO UPTAKE OF DRUG IN HELA CELLS | 11 | 48 |
| 2198 | 4 | 21 | 1853 1969 CANCER RESEARCH 29 (8): 1590-& SIMARD R; CASSINGE.R ACTINOMYCIN RESISTANCE IN CULTURED HAMSTER CELLS | 3 | 27 |
| 2199 | 6 | 36 | 1854 1969 CANCER RESEARCH 29 (10): 1859-& POST J; HOFFMAN J EFFECTS OF 5-IODO2+-DEOXYURIDINE UPON REPLICATION OF ILEAL AND SPLEEN CELLS IN VIVO | 5 | 14 |
| 2200 | 4 | 42 | 1855 1969 CANCER RESEARCH 29 (12): 2195-& BATES HM; KUENZIG W; WATSON WB STUDIES ON MECHANISM OF ACTION OF ANTHRAMYCIN METHYL ETHER, A NEW ANTITUMOR ANTIBIOTIC | 4 | 22 |
Page 22 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
Generated by: HistCite 2005.08.29